SCHEMBL5366336

SCHEMBL5366336

O=C(CI)c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL711360 0.82 RAB9A (0.75)
SCHEMBL2216212 0.82 ALDH1A1 (1.00)
SCHEMBL6197414 0.81 ALDH1A1 (0.80)
SCHEMBL318272 0.80 ALDH1A1 (0.71)
SCHEMBL23855456 0.80
SCHEMBL22721189 0.78 ALDH1A1 (0.83)
SCHEMBL9608874 0.78
SCHEMBL230036 0.78
SCHEMBL658097 0.78
SCHEMBL11407883 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117925782-A Composition for nucleic acid hybridization and application thereof 深圳吉因加医学检验实验室 2024-04-26 CN disclosed
EP-1254930-B1 Particles for electrophoresis, a production method thereof and a display using the particles CANON KK (JP) 2008-06-18 EP disclosed
US-20070191388-A1 SUBSTITUTED NAPHTHYRIDINE DERIVATIVES AS INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND THEIR USE IN THE TREATMENT OF HUMAN DISEASES AVANIR PHARMACEUTICALS (US) 2007-08-16 US disclosed
US-7169550-B2 Diffraction-based diagnostic devices KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-01-30 US disclosed
WO-2004029596-A1 DIFFRACTION-BASED DIAGNOSTIC DEVICES KIMBERLY-CLARK WORLDWIDE, INC. (US) 2004-04-08 WO disclosed
US-20040063146-A1 Diffraction-based diagnostic devices KIMBERLY-CLARK WORLDWIDE, INC. 2004-04-01 US disclosed